β-Lactamase–Producing, Ciprofloxacin-Resistant Neisseria meningitidis Isolated From a 5-Month-Old Boy in the United States-Reference-Cited by-同舟云学术

β-Lactamase–Producing, Ciprofloxacin-Resistant Neisseria meningitidis Isolated From a 5-Month-Old Boy in the United States

Published:2020-08-03 Issue:3 Volume:10 Page:379-381
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Taormina Gillian¹,Campos Joseph²,Sweitzer John³,Retchless Adam C⁴,Lunquest Kristy³,McNamara Lucy A⁴^ORCID,Reese Natashia⁵,Karlsson Maria⁵,Hanisch Benjamin¹^ORCID

Affiliation:

1. Children’s National Hospital, Division of Infectious Diseases, Washington, District of Columbia, USA

2. Children’s National Hospital, Department of Microbiology, Washington, District of Columbia, USA

3. Maryland Department of Health, Baltimore, Maryland, USA

4. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

5. Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Abstract

Abstract Worldwide, there have been few reports of β-lactamases causing penicillin resistance in Neisseria meningitidis. The first known case of disease in the United States due to a β-lactamase-producing, ciprofloxacin-resistant N. meningitidis was recently identified. This has potential implications on standard laboratory testing and empiric management of meningococcal disease.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology, and Child Health

Link

http://academic.oup.com/jpids/article-pdf/10/3/379/36872652/piaa085.pdf

Reference13 articles.

1. Meningococcal infections.;American Academy of Pediatrics,2018

2. Penicillin use in meningococcal disease management: active bacterial core surveillance sites, 2009;Blain;Open Forum Infect Dis,2016

3. Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States;Harcourt;Open Forum Infect Dis,2015

4. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents;Jorgensen;J Clin Microbiol,2005

5. WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 β-lactamase gene;Tsang;J Antimicrob Chemother,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cephalosporins in pediatrics: Navigating antimicrobial resistance impact and adverse effects – A comprehensive review;IP Indian Journal of Clinical and Experimental Dermatology;2024-06-15

2. Meningococcal disease in North America: Updates from the Global Meningococcal Initiative;Journal of Infection;2022-12

3. Antibiotic Sensitivity of <i>Neisseria meningitidis</i> Isolated From Patients with Generalized Forms of Meningococcal Infection and From Healthy Carriers;Antibiotics and Chemotherapy;2022-09-08

4. Global genomic and proteomic analysis indicates co-evolution of Neisseria species and with their human host;World Journal of Microbiology and Biotechnology;2022-07-01

5. Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase–Positive, Serogroup Y Neisseria meningitidis in the United States;Clinical Infectious Diseases;2021-04-26